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Abstract: The guanylyl cyclase-activating protein 1, GCAP1, activates or inhibits retinal guanylyl 
cyclase (retGC) depending on cellular Ca2+ concentrations. Several point mutations of GCAP1 have 
been associated with impaired calcium sensitivity that eventually triggers progressive retinal 
degeneration. In this work, we demonstrate that the recombinant human protein presents a highly 
dynamic monomer-dimer equilibrium, whose dissociation constant is influenced by salt 
concentration and, more importantly, by protein binding to Ca2+ or Mg2+. Based on small-angle X-
ray scattering data, protein-protein docking, and molecular dynamics simulations we propose two 
novel three-dimensional models of Ca2+-bound GCAP1 dimer. The different propensity of human 
GCAP1 to dimerize suggests structural differences induced by cation binding potentially involved 
in the regulation of retGC activity. 
Keywords: quaternary assembly; calcium-binding proteins; EF-hand; protein-protein interaction; 
small-angle X-ray scattering; molecular dynamics simulations; protein modeling; protein dynamics; 
size exclusion chromatography; multi-angle light scattering 
 
1. Introduction 
In photoreceptor cells, light photons are transformed into electric signals by the coordinate 
interplay of a complex network of proteins, regulated by different chemical messengers [1].  
Guanylyl cyclase-activating protein 1 (GCAP1) belongs to the calmodulin superfamily and hosts 
4 EF-hand motifs (EF1–EF4). At low Ca2+ concentration (< 100 nM) GCAP1 EF2 can bind at least one 
Mg2+ ion [2] activating retinal guanylyl cyclase 1 (retGC1) [3,4]. Active retGC1, in turn, replenishes 
the second messenger cGMP, switching off the light-activated cascade and restoring the 
photoreceptors′ dark state. High cGMP concentration increases the influx of Ca2+ through the cyclic 
nucleotide-gated (CNG) channels determining GCAP1 Ca2+-bound state (EF2-4 bind 3 Ca2+ ions) that 
inhibits retGC1 activity. During evolution, GCAP1 N-terminal EF-hand (EF1) lost the capability to 
bind calcium and became involved in the binding of retGC1 and modulation of its activity [5–7]. 
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So far, 22 pathological point mutations of GCAP1 have been identified, which are associated 
with an autosomal dominant cone or cone-rod dystrophy [8]. Such mutations usually induce a lower 
affinity for Ca2+ determining the deregulation of retGC1 at physiological calcium levels, with 
progressive degeneration of the cone photoreceptors [9,10]. Nevertheless, exceptions exist for 
substitutions at the N-terminal domain (L84F and L176) that do not perturb the affinity for Ca2+ in the 
respective GCAP1 variants [11] [12]. Recent work suggests also the involvement of GCAP1 in retinitis 
pigmentosa, a severe form of progressive rod-cone dystrophy [13]. 
It is known that purified GCAP1 displays both monomeric and dimeric species [14]. Recently 
the dimeric assembly raised particular interest for its possible involvement in retGC1 regulation [15] 
[16]. The dimeric assembly proposed by Lim et al. [15] involves contacts between residues comprised 
in EF1 and EF2 motifs, i.e., in the portion of the protein that is thought to interact with retGC1, 
specifically His19, Tyr22, Phe73, and Val77. Mutations of these residues abolished the dimeric 
assembly as proven by analytical gel filtration [15]. 
In this work, we performed several experiments on recombinant human (h) GCAP1, to 
thoroughly analyze the dimeric assembly. Microscale thermophoresis, size exclusion 
chromatography (SEC) and small-angle X-ray scattering (SAXS) data confirmed the presence of a 
monomer-dimer equilibrium in solution influenced by Ca2+ or Mg2+ binding and by ionic strength.  
Using the ZDOCK program [17] for rigid-body protein–protein docking, we produced a large 
number of possible dimeric assemblies, ranked using the empirical docking score, and filtered 
according to the fulfillment of distance constraints imposed by previous EPR double electron-electron 
resonance (DEER) experiments [15]. The best 3 dimers were selected for further characterization and 
optimization by molecular dynamics (MD) simulations and analyzed with SEC-SAXS data collected 
at the highest protein concentration. The optimized dimeric structures were used to predict the 
change in the free energy of binding (ΔΔG°) upon mutations, which are known to induce GCAP1 
monomerization [15]. The two resulting three-dimensional models of dimeric GCAP1 in its Ca2+-
bound form presented in this work, recapitulate all current experimental lines of evidence from us 
and other authors and might have implications on the regulatory activity of GCAP1. 
2. Materials and Methods  
2.1. Human GCAP1 Expression and Purification 
To produce the N-terminal myristoylated hGCAP1, the recombinant plasmid pET11a carrying 
the cDNA sequence was co-transformed in the E. coli strain BL21-CodonPlus RP (Agilent 
Technologies, Santa Clara, CA, USA) together with a pBB131 plasmid carrying the coding sequence 
for yeast N-myristoyltransferase (NMT). The hGCAP1 construct has the E6S mutation needed for the 
post-translational myristoylation.  
Cell cultures were grown at 37 °C in 2 l of LB medium containing 100 µg/mL ampicillin (Amp), 
30 µg/mL kanamycin (Kan), and 34 µg/mL chloramphenicol (Cm). The myristic acid (220 µM) was 
added when the culture reached the OD600 = 0.4. Fifteen min later, the expression of hGCAP1 and 
NMT was induced by the addition of 1 mM IPTG. Cells were harvested after 3 h at 37 °C and frozen 
at –20 °C. 
Typically, 3 g of E. coli cells were resuspended in lysis buffer (50 mM Tris-HCl pH 8.0, 50 mM 
NaCl, 10 µg/mL Deoxyribonuclease I, 20 mM MgSO4, 5 mM DTT, and protease inhibitors (cOmplete, 
Roche, Basel, Switzerland) and lysed by high-pressure cell disruptor (Basic Z Bench Top; Constant 
Systems Limited, Daventry, Northants U.K.) at 25 KPSI. The crude extract was centrifuged at 38,700× 
RCF for 30 min and filtered through a 0.45 µM filter. The clarified soluble extract was loaded in a 
HiPrepTMQ XL 16/10 (GE Healthcare Life Sciences, Boston, MA, USA) in loading buffer (50 mM Tris-
HCl pH 8.0, 50 mM NaCl, 2 mM EDTA, 5 mM DTT) and eluted with a linear gradient of NaCl (from 
0.2 to 1 M). 
Fractions corresponding to hGCAP1 were pooled, concentrated, and passed through a 
HiLoadTM 16/600 SuperdexTM75 pg (GE Healthcare Life Sciences) equilibrated with 20 mM 
Tris/HCl pH 8.0, 100 mM NaCl, 5 mM DTT, 1 mM CaCl2, and one cOmplete protease inhibitor tablet. 
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All the purification steps were performed using an ÄKTA pure 25L (GE Healthcare) at 4 °C and 
analyzed with SDS-PAGE. 
To obtain the apo form of hGCAP1, the protein was further purified using a hydrophobic 
interaction chromatography, decreasing the NaCl concentration from 300 mM to 0 mM. EGTA was 
added at 4 mM concentration both in the loading and the elution buffer. 
2.2. Circular Dichroism 
Far-UV Circular Dichroism (CD) spectra of hGCAP1 with and without Ca2+ were recorded in a 
Jasco J-810 spectropolarimeter (JASCO Europe, Cremella, Italy) equipped with a Jasco temperature 
controller module PFD-425S. All measurements were performed in a 0.1 cm path length quartz 
cuvette at 0.2 mg/mL protein concentration in 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2mM DTT, 
added with 2 mM Ca2+ or 2 mM EGTA. Far-UV spectra were recorded from 190 to 260 nm, at 20 and 
95 °C (temperature was increased in ramp mode at 1 °C/min). 
2.3. Analytical Size Exclusion Chromatography 
To study the monomer-dimer equilibrium of the Ca2+-bound hGCAP1 the protein buffer was 
exchanged into 20 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM DTT, 5 mM CaCl2 using a PD-10 
Desalting Column (GE Healthcare). Calcium was substituted with 5 mM MgCl2 and 2.5 mM EGTA 
to study the Mg2+-bound protein. 
Different protein dilutions were prepared (87 µM, 43 µM, 21 µM, 10 µM, 4 µM, 2 µM) and 
injected (200 µL) in a SuperdexTM75 Increase 10/300 GL column (GE Healthcare Life Science) with 
0.8 mL/min flow rate. 
Assuming a linear dependency of Ve from the logarithm of the Mw (Ve = A × log(Mw) + B) and 
assuming that in the presence of a monomer-dimer equilibrium the apparent Mw is related to the 
percentage of each species through the equation Mw = (%dim × 22.9 + 22.9) we get the relation Ve = 
A × log((%dim × 22.9 + 22.9)) + B. Describing the monomer-dimer equilibrium through the 
dissociation constant Kd we arrive at the 3 parameters (A, B, and Kd) equation to fit the Ve vs. 
concentration (c) curve: 
Ve = A∙log (22.9∙(1 − Kd/4c∙( − 1 + (1 + 8c/Kd)(0.5))) + 22.9) + B 
2.4. Microscale Thermophoresis (MST) 
The human GCAP1 was labeled with the red fluorescent dye NT-647-NHS with the Monolith 
NTTM Protein Labeling kit according to the manufacturer protocol (Nanotemper Technologies, 
München, Germany). The NT-647-NHS carries a reactive NHS-ester group that reacts with primary 
amines (lysine residues) to form a covalent bond, achieving about 1:1 ratio of labeled protein to dye. 
The dye solution was prepared at 30 µM in the supplied labeling buffer. GCAP1 (10 µM) was diluted 
in a 1:2 ratio with the labeling solution and incubated at room temperature for 30 min. Sixteen serial 
dilutions of unlabeled protein were prepared from 46.6 µM to 11.4 nM in 20 mM Tris-HCl, 100 mM 
NaCl, pH 7.5, 1 mM DTT, 5 mM CaCl2 supplied with 0.05% Tween20. Labeled hGCAP1 (10 nM) was 
added in each of the sixteen dilutions and the reactions were loaded in sixteen capillaries. After 
confirming that the fluorescence of each capillary was constant, the MST traces were recorded at 24 
°C with 40% laser excitation power and 40% MST power.  
The same experiments were repeated using a 20 mM Tris-HCl, 150 mM KCl, 5 mM MgCl2, 2.5 
mM EGTA, pH 7.5, 1 mM DTT buffer supplied with 0.05% Tween20 to study the magnesium-bound 
hGCAP1. 
All the MST experiments were carried out with a Monolith NT.115 (Nano Temper Technologies). 
Kd values were calculated as the average of the triplicate experiments analyzed with MO.Affinity 
Analysis 3 software. 
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2.5. Dynamic Light Scattering 
hGCAP1 were concentrated to 175 µM in 20 mM Tris-HCl pH 8, 5 mM 2-mercaptoethanol, and 
filtered through a 0.22 µm filter (Merck Millipore Ltd. Burlington, MA, USA). Eighty microliters of 
protein solution were used to measure hydrodynamic radius by DLS. Measurements were performed 
using a DynaPro instrument (Protein Solutions, Charlottesville, VA, USA) in a thermostatic cuvette 
at 10 °C. 
2.6. SEC-MALS  
Size-Exclusion Chromatography (SEC) combined with Multi-Angle Light Scattering (MALS) 
detection was performed in an HPLC system composed by a Waters 515 HPLC Pump, a Waters 2487 
Dual λ Absorbance detector (Waters, Sesto San Giovanni, Italy), a Wyatt Dawn Heleos MALS and a 
Wyatt Optila T-rEX differential refractive index detector (Wyatt Technology, Santa Barbara, Ca).  
200 µL of 2 mg/mL GCAP1 samples were run on a Superdex 75 Increase 10/300 GL column (GE 
Healthcare, Milan, Italy), by using 20 mM Tris-HCl, pH 8, 5 mM 2-mercaptoethanol, with/without 1 
mM CaCl2, as mobile phase, at a flow rate of 0.8 mL/min. Molar masses were calculated by means of 
the Astra V software vs. 5.3.4.20 (Wyatt), using a dn/dc value of 0.185. 
2.7. Trp Fluorescence 
The Trp fluorescence of the hGCAP1 was measured diluting the protein concentration at 3 µM 
in the followed three different buffers: calcium buffer (20 mM Tris-HCl, 150 mM KCl, pH 8, 5 mM 
DTT, 1mM CaCl2), magnesium buffer (20 mM Tris-HCl, 150 mM KCl, pH 8, 5 mM DTT, 1mM MgCl2, 
1mM EGTA), EGTA buffer (20 mM Tris-HCl, 150 mM KCl, pH 8, 5 mM DTT, 1mM EGTA). All the 
measurements were performed in a Varian Cary Eclipse fluorescence spectrophotometer using a 280 
nm excitation wavelength, 300–400 nm emission wavelength, setting the slit at 10 nm, and the 
temperature at 25 °C. 
2.8. SAXS Data Collection 
The SAXS data of hGCAP1 were collected with λ = 0.9919 Å after elution from the analytic SEC 
(Superdex75 Increase 10/300 GL) at ESRF beamline BM29 with Pilatus 1M detector with 1 sec 
exposure time. 
The 2700 frames of hGCAP1 in EGTA (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 5mM EGTA, 5mM 
DTT) were collected at 20 °C: the selected peak comprised 47 frames (1372-1419) that were scaled in 
groups of three and subtracted from the buffer (frames 15–194) considering each slightly different 
concentration (from UV absorbance) before subtraction.  
The SEC-SAXS data of hGCAP1 in Mg2+ (20 mM Tris-HCl pH 8.0, 5 mM MgSO4, 2.5 mM EGTA, 
150 mM KCl, 5mM DTT) and Ca2+/Mg2+ (20 mM Tris-HCl pH 8.0, 5 mM CaCl2, 5mM MgSO4, 150 mM 
KCl, 5mM DTT) were collected at 4 °C. The selected peak of hGCAP1 in Ca2+/Mg2+ at the higher 
protein concentration comprised 41 frames (1330-1371, buffer frames 172–525). The data analysis was 
performed using programs PRIMUS 3.0 [18] and ScÅtter 3 (http://www.bioisis.net)).  
2.9. Model of hGCAP1 Dimeric Assembly and Molecular Dynamics Simulations 
Different possible dimeric conformations were generated using the equilibrated structure of 
Ca2+-loaded hGCAP1 reported in [19] as the monomeric unit. The structure was subjected to three 
independent rigid body docking simulations using ZDOCK 3.0.2 [20] with a sampling step of 6° 
(dense sampling) starting from different relative orientations, each resulting in 4000 complexes. All 
the 12,000 resulting dimers were then filtered according to the distance constraints identified by Lim 
et al. [15]. The standard deviation of such constraints was increased by 50% to include correctly the 
distances between Cαs and the limits of rigid-body docking, resulting in the following constraints: 
42.5 Å < d (E57–E57) < 57.5 Å; 42.5 Å < d (E133–E133) < 57.5 Å, and, 23.5 Å < d (E154–E154) < 32.5 Å. 
The 3 final dimers, resulting from the highest-scored filtered complex from each of the three docking 
runs, were then fused to a randomly generated C-terminal (17 amino acids).  
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The three dimers (d1, d2, and d3) were then subjected to 200 ns all-atom MD simulations using 
GROMACS v. 2016.1 [21] with CHARMM36m [22] as a force field, after manual addition of the 
parameters for the myristoylated Gly at the N-term [23]. The simulated systems consisted of a 
dodecahedral box (~11.5 × 11.5 × 8.2 nm3) comprising 30673–33644 water molecules, 93-96 K+ ions, 
13–14 Mg2+ ions, and 95-101 Cl− ions for a total of 98566–107500 atoms, depending on the specific 
dimer. The protocols for energy minimization, equilibration, and production were the same as in 
Marino et al. [4]. 
For each trajectory, 2.000 frames were extracted at 100 ps intervals and the average χ2 with 
respect to SAXS data over the last 100 ns of the trajectory was calculated using the program CRYSOL 
2.8 [24] both considering and discarding the C-term. Indeed, the presence of the highly mobile C-
term was found to greatly affect the agreement with SAXS data making it difficult for the selection of 
the correct dimer interface. To include in the analysis the mobility of each dimeric assembly along 
with the simulations we used the program EOM 2.1 [25] (with saxns_fit2eom script; 
http://xray.utmb.edu/SAXNS) that builds a mixed model selecting different structures along the 
simulations to enhance the agreement with SAXS data. 
From each trajectory, the frame displaying the lowest absolute χ2 without C-ter (i.e., 162 for d1, 
1878 for d2, and 1921 for d3) was selected as the representative model for each dimer, namely d1′, 
d2′, and d3′, respectively. 
In such dimers, the two chains were separated and subjected again to rigid-body docking using 
ZDOCK 2.3 [26]. For each complex, 4 docking simulations were performed (1 with the original 
relative orientation and 3 with randomly generated orientations) each with 4.000 solutions and 
rotational sampling 6°. The 16,000 solutions for each complex were clustered into a group of native-
like poses having a Cα RMSD < 1 Å with respect to the original complex. The average ZDOCK score 
(ZD-s) was then calculated for the native-like poses to estimate the binding free energy using the 
correlation explained in [27] (ΔG0 = 3.86-0.39 × ZD-s).  
Finally, in silico mutagenesis of the variants known to interfere with the dimerization process, 
namely H19R, Y22D, F73E, and V77E [15], on both monomers of the best complexes (d1′ and d2′) 
were obtained using Maestro (Schroedinger) software. The rotamers for each residue were selected 
according to the most probable non-clashing rotamer ranked by the “mutate residue” function of 
Maestro. The four variants were docked using ZDOCK 2.3 [26], using the same protocol as previously 
described for the WT homodimers, and the relative change in binding free energy with respect to the 
WT (ΔΔG0) was calculated. The persistence of electrostatic interactions over the 200 ns trajectories 
was calculated using PyInteraph 1.0 software [28], which calculates the percentage of the trajectory 
frames where the distance constraints between oppositely charged residues are fulfilled (3.5 Å).  
3. Results 
3.1. hGCAP1 Expression and Purification 
The recombinant hGCAP1 was expressed in E. coli BL21-CodonPlus RP cells with N–terminal 
myristoylation (Myr). In such conditions, we expected an efficient cut of the N-ter Met (> 97%) [29] 
followed by an effective N–terminal myristoylation (> 95%). The protein was purified from the 
soluble fraction of the cell lysate by ion-exchange chromatography followed by size exclusion 
chromatography. The purification yield was typically 10 mg (protein)/g (cells). 
3.2. Thermal Denaturation of hGCAP1 
Thermal denaturation of hGCAP1 with and without Ca2+ was detected using circular dichroism 
spectroscopy. The ellipticity at 220 nm of the Ca2+/EGTA protein varied from –26/–27 mdeg (at 20 °C) 
to –19/−22 mdeg (at 95 °C) (Figure S1). In both cases, the persistence of the ellipticity signal at high 
temperature demonstrates a non-complete denaturation of the protein and the conservation of most 
of the alpha-helical structures. Such evidence suggests that the EF-hand motifs could remain well 
folded and functional even at extreme conditions [30]. 
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3.3. Monomer-Dimer Equilibrium of hGCAP1 in the Presence of Ca2+ or Mg2+ 
We used analytical size exclusion chromatography (SEC) to study the monomer-dimer 
equilibrium of hGCAP1 (molecular weight, Mw = 22.9 kDa). Comparing the elution volume (Ve) of 
the Ca2+ bound hGCAP1 (Ve = 10.89 mL) with that of 5 reference proteins (from Aprotinin, Mw = 6.5 
kDa to Conalbumin, Mw = 75 kDa) it was possible to estimate its molecular weight at 49 kDa, 
compatible with a dimeric assembly. In these experimental conditions, the hGCAP1 concentration at 
the elution peak, calculated from UV absorbance at 280 nm (Mw/ε = 1.07 mg/mL), was 17.7 µM. 
Reducing the protein concentration, the SEC peak shifted toward higher Ve (i.e., lower apparent Mw), 
suggesting the presence of a monomer-dimer equilibrium. 
To characterize such equilibrium, we performed six analytical SEC experiments in the presence 
of Ca2+ (Figure 1A). Ve depends on protein apparent Mw which, in turn, is related to the dissociation 
constant (Kd) of the monomer-dimer equilibrium. Therefore, it is possible to represent the variations 
of Ve with protein concentration with an equation depending on 3 free parameters, including Kd 
(Figure 1C). Using this analysis, we estimated a Kd of 8.8 ± 0.7 µM for the calcium-bound hGCAP1 
(fitting curve in Figure 1, lower left panel). 
The same experiment in EGTA/Mg2+ buffer (Figure 1B) allowed to calculate a higher value for 
the dissociation constant (Kd = 45 ± 15 µM; Figure 1D). These results demonstrate that the Ca2+ bound 
protein is more prone to dimerize than the Mg2+ bound protein. 
 
Figure 1. Dissociation constants calculated from size exclusion chromatography (SEC) experiments. 
SEC experiments in presence of Ca2+ (A) or Mg2+ (B) at different protein concentrations. In the lower 
panels (C and D) are reported the corresponding variations of elution volumes (Ve) with protein 
concentration (black dots) together with the 3-parameters theoretical curves fitting the experimental 
data (black lines). 
3.4. Monomer-Dimer Equilibrium of hGCAP1 Analysed with Microscale Thermophoresis 
We performed additional experiments to determine the hGCAP1 dimer dissociation constant 
using microscale thermophoresis. We assumed that the labeled protein (with NT-647-NHS 
fluorescent dye) at low concentration (20 nM) was monomeric. Therefore, the addition of increasing 
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amounts of unlabeled protein-induced changes in labeled protein fluorescence depending on the 
formation of the dimeric assembly (Figure 2). In this way, we calculated a monomer-dimer 
dissociation constant for the Ca2+ bound hGCAP1, Kd = 9.4 ± 1.3 µM (Figure 2, blue points/curve) in 
agreement with the SEC results. The same experiment repeated in the presence of Mg2+/EGTA 
resulted in a Kd one order of magnitude higher (Kd = 77.2 ± 8.9 µM; Figure 2, red points/curve). 
 
Figure 2. Microscale thermophoresis of the hGCAP1 monomer-dimer transition in Ca2+and Mg2+. 
Changes in labeled protein fluorescence as a function of unlabeled hGCAP1 concentration in the 
presence of Ca2+ (blue points) or Mg2+ (red points) together with the curves fitting the two experiments 
(law of mass action) in blue and red, respectively. 
3.5. Monomer-Dimer Equilibrium is Affected by Ionic Strength 
Additional SEC experiments were performed varying the concentration of apo hGCAP1 
(obtained as described in Materials and Methods), in a buffer with low ionic strength (20 mM Tris-
HCl, 5 mM 2-mercaptoethanol, pH 8.0). These experiments showed constant values of the elution 
volumes, indicating the loss of the monomer-dimer equilibrium and the presence of a single 
quaternary assembly. Multi-angle light scattering coupled with SEC (SEC-MALS) analysis showed 
an Mw corresponding to the hGCAP1 monomer (Mw~ 23 kDa; Figure 3, red curve). In low ionic 
strength conditions, hGCAP1 remained monomeric even at high concentration (175 µM), as shown 
in dynamic light scattering (DLS) experiments that estimated an Mw of 24 kDa (18% polydispersion). 
Interestingly, the addition of a low amount of calcium (1 mM) to the salt-free buffer was 
sufficient to induce again the monomer-dimer equilibrium, with a protein molecular weight 
calculated from MALS of about 29 kDa (Figure 3, blue curve). The slightly higher hydrodynamic 
radius of the apoprotein (Figure 3, red curve) can be explained by intramolecular repulsive effects 
due to the protein net charge in the salt-free buffer and by the increased exposition of hydrophobic 
surface that requires a thicker solvation shell [30]. 
An analogous result was also observed for chicken GCAP1 (data not shown) demonstrating that 
the binding of calcium is a determinant factor to promote GCAP1 dimerization. 
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Figure 3. Multi-angle light scattering coupled with SEC (SEC-MALS) of hGCAP1 in the salt-free 
buffer. Without salt hGCAP1 is monomeric (Mw 23 kDa; red curves) and it moves toward the 
monomer-dimer equilibrium upon the addition of 1 mM Ca+2 (Mw ~29 kDa, blue curves). The thick 
lines represent the molar mass measured by MALS (legend on the right) in correspondence to each 
SEC peak (solid lines; legend on the left); the dashed lines represent the scattering signal (legend on 
the left). 
3.6. hGCAP1 Trp Fluorescence in the Different Ion Binding States 
hGCAP1 hosts 2 tryptophan residues: Trp21, in the Myr cavity, and Trp94, between EF2 and EF3 
hand motifs. The Trp fluorescence measured in the presence of Mg2+ or EGTA showed similar values 
of maximum emission wavelength (343.5 and 343.3 nm, respectively). Such values are correlated with 
significant solvent exposure of tryptophan, as discussed by Vivian and Callis [31], that showed a 
variation range of maximum emission wavelength between 310 and 350 nm for completely buried or 
completely exposed Trp, respectively. In the presence of saturating Ca2+ concentration (5 mM) we 
registered a 2 nm redshift of the emission peak (345.2 nm), indicating that Ca2+ binding slightly 
increases the solvent exposure of Trp (Figure S2). Such evidence suggests a slightly higher 
hydrodynamic radius of the Ca2+-bound form in agreement with the lower elution volumes observed 
in SEC experiments (Figure 1, upper panels). Similar behavior was observed for bovine GCAP1 which 
showed a change from 345 to 347 nm upon Ca2+ addition [32]. Such structural changes induced in 
GCAP1 by calcium-binding are likely correlated with the promotion of the dimeric assembly as 
observed for the Ca2+ bound protein with respect to the Mg2+ bound moiety. 
3.7. SAXS Analysis of the hGCAP1 Monomer 
The SEC-SAXS analysis of hGCAP1 at low concentration (10.9 µM) (analyzed using programs 
PRIMUS 3.0 [18] and ScÅtter 3 (http://www.bioisis.net/)) without Ca2+ (20 mM Tris-HCl pH 7.5, 150 
mM NaCl, 5 mM EGTA, 5 mM DTT) showed a Mw, estimated from scattering intensity relative to 
water at zero angle (I0 = 18.29 ± 0.06), of 21.1 kDa [33], compatible with a monomeric assembly (Rg = 
21.7 ± 0.1 Å; Figure 4A). After regularization and real space transformation (program GNOM; ATSAS 
3.0.1 [34]; Dmax = 60 Å; Figure 4B) the superposition of a typical low resolution model (program 
DAMMIN 5.3 [35]; Figure 4, upper panel)) on cGCAP1 crystal structure (pdb-id: 2r2i; Dmax~ 50 Å; 
Figure 4C) shows that hGCAP1 occupies a slightly larger volume. Anyway, the modest agreement of 
cGCAP1 with the SAXS data (program CRYSOL [24]; χ2 = 2.62) was greatly improved by the addition 
of the missing 17 C-terminal residues (with program CORAL 1.1 [36]; χ2 = 1.43; Figure 4D,E). 
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Figure 4. SEC-SAXS data of hGCAP1 monomer. (A) experimental SEC-SAXS data of hGCAP1 without 
Ca2+ or Mg2+ at 10.9 µM (Rg = 21.5 Å; blue points) with GNOM regularization (red line) and (B) 
corresponding P(R) (Dmax = 60 Å). (C) DAMMIN most typical low-resolution model (cyan surface; 
ensemble resolution = 25 ± 2 Å; superposed to the crystal structure of cGCAP1 (NSD 2.09; pdb-id 2r2i; 
Rg = 19.8 Å; blue cartoons). (D) experimental data fitted with cGCAP1 without C-ter (CRYSOL χ2 = 
2.62; green curve) or with C-ter (added with CORAL; red curve; χ2 = 1.43). (E) hGCAP1 model 
obtained adding to the chicken protein (blue cartoons) the C-ter with coral (red cartoon). The pictures 
of protein structures were prepared with the PyMOL 2.2.0 program (The PyMOL Molecular Graphics 
System, Version 2.0 Schrödinger, LLC). 
3.8. SEC-SAXS Evidence of the Monomer-Dimer Equilibrium 
We collected SEC-SAXS data of hGCAP1 in different buffers and at different protein 
concentrations. The SEC absorbance peaks were used to estimate protein concentrations to properly 
scale the scattering data before averaging and buffer subtraction. By comparing the scattering data 
extrapolated at zero angles of protein and water as a reference, it is possible to estimate the protein 
Mw (Table 1). As discussed above, apo hGCAP1 (in EGTA) is monomeric at low concentration (10.9 
µM). On the contrary, when bound to Ca2+ or Mg2+, hGCAP1 evolves toward different monomer-
dimer equilibria whose Kd depends on the binding state of the EF-hands motifs, as already described. 
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EGTA 10.9 21.5 18.2 21.1 100 60 29.4 28.2 
Mg2+ 59.4 22.4 32.3 35.9 43 75 29.0 28.8 
Ca2+/Mg2+ 25.3 24.1 31.6 35.2 46 76 27.4 27.1 
Ca2+/Mg2+ 51.1 24.5 39.2 43.7 9 81 35.2 38.0 
Ca2+/Mg2+ ~76 b 24.5 - - - 81 40.8 45.6 
a Concentrations based on peak absorbance. b This concentration was not measured directly due to 
experimental problems; therefore, the reported value is estimated, and it does not allow the analysis 
based on I0 values. c Mw calculated using the program PRIMUS and relative scale respect to water I0 
(0.0156 for EGTA sample and 0.0162 for the other samples). 
In particular, Ca2+ bound protein displays an Mw varying from 35.2 kDa (at 25.3 µM) to 43.7 (at 
51.1 µM). 
The SEC-SAXS data of calcium bound GCAP1 collected at the higher protein concentration (~76 
uM; Table 1), corresponding to a prevalent dimeric assembly (Rg = 24.5 ± 0.1 Å), were regularized 
and transformed in real space with the program GNOM (ATSAS 3.0.1) [34]; real space Rg = 24.8 ± 0.1 
Å, Dmax = 80 Å; Figure 5A), and then used to produce several low resolutions models using 
DAMMIF (ATSAS 3.0.1) with P2 symmetry ([37]; ensemble resolution = 29 ± 2 Å; Figure 5C). These 
data were also used to select between different possible dimeric assemblies as described in the next 
paragraph. 
3.9. Modelling and Selection of Possible Dimeric Assemblies 
The three-dimensional structural model for hGCAP1 (201 amino acids, 22.9 kDa) was obtained 
by homology modeling using the X-ray structure of cGCAP1 (pdb-id: 2r2i, sequence identity of 84%; 
[38]) as a template. Analysis of the possible protein-protein interfaces hosted in the cGCAP1 
crystallographic packing of the chicken protein with the PDBePISA server [39] did not reveal any 
stable dimeric assembly. However, previous work [15] based on DEER provided structural hints as 
to the dimeric nature of bovine GCAP1 and defined specific distance-constraints among residues 
belonging to each monomer, resulting in two alternative dimeric assemblies a symmetric and an 
asymmetric one. 
In view of these lines of evidence, the homology modeled and equilibrated structure of hGCAP1 
described by Marino and Dell’Orco [19] was used to produce 12,000 random dimers with rigid body 
docking using the program ZDOCK 3.0.2 [20]. The dimers were then filtered according to the distance 
constraints between the 4 residues identified by Lim et al., [15] i.e., His19, Tyr22, Phe73, and Val77 
(see Methods) resulting in 36 to 43 filtered poses for each independent docking run obtained by 
randomizing the initial position of the probe. The three assemblies presenting the highest ZDOCK 
3.0.2 score in each independent and randomized docking run (p1, p2, and p3) were significantly 
different from each other (Cα-RMSD values were: 4.48 Å for p1–p2, 14.49 Å for p2–p3 and 12.73 Å 
for p1–p3). The three best-scored dimers (from now on named dimers d1, d2, and d3) were then fused 
with a randomly generated C-terminus and subjected to 200 ns all-atom MD simulations sampling a 
total of 2000 frames (one every 100 ps). 
Firstly, we analyzed the agreement of the identified dimers along each respective MD trajectory 
omitting the highly mobile C-terminal tail (i.e., the last 17 amino acids) of every monomer. The 
average χ2 calculated on the final 50 ns of the MD simulations (Figure S3) shows that dimers d2 and 
d3 display a comparable agreement with scattering data (<χ2> = 2.79 and 3.71, respectively), whereas 
d1 exhibits a poorer agreement (<χ2> = 13.45). The ranking changes when considering in the models 
also the conformations of C-ter, with d1 and d2 being in comparable agreement with SAXS (<χ2> = 
3.02 and 3.40, respectively) and d3 in disagreement (<χ2> = 13.79) (Figure S4). To take into account 
also the dynamics of the proteins along with the 3 simulations (including the C-ter) we used the 
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program EOM 2.0 (Ensemble Optimisation Method; [25]) that builds a mixed/dynamical model for 
every simulation with the weighed contribution of different structural states to fit the SAXS data. 
Again, the dynamical analysis confirmed d1 and d2 as the best assemblies (χ2 = 1.16 and 1.17, 
respectively) and d3 as the worst (χ2 = 2.37) (Figure 5B). 
To summarize, the agreement with SAXS data of d1 and d2 improves by adding the C-ter amino 
acids and it gets even better when protein dynamics are explicitly considered. On the contrary d3—
the best dimer in the absence of C-ter—worsens considerably when taking into account the 
contribution of the C-ter end. 
For each MD simulation, the structural conformation showing the lowest χ2 with respect to the 
SAXS data (without C-ter; Table 2) (named d1′,d2′,d3′) was subjected again to rigid-body docking 
using another version of the ZDOCK algorithm (ZDOCK 2.3) to obtain an estimate of the free energy 
of binding, using an empirical correlation with the ZDOCK score as explained in [27]. This approach 
has demonstrated to be useful to predict in silico the effects of any point mutation affecting the dimer 
interface on the relative free energy of binding (ΔΔG0), under the assumption that mutations do not 
significantly perturb the structure of each interacting molecule. The scores of SAXS and ZDOCK 
analysis are reported in Table 2. 
3.10. Computational Analysis of Mutations in hGCAP1 Dimeric Assembly 
All the dimers predicted by the rigid-body docking algorithm accounting for shape and 
electrostatic complementarity and desolvation of residues buried at the dimer interface (ZDOCK 2.3) 
resulted in high-score poses, and 16–24 of the 12,000 poses reconstituted within 1 Å (Cα-RMSD; 
“native-like” poses; Table 2) with respect to dimers d1′,d2′,d3′ (Table 2). As it has been proven that, 
in the absence of major conformational changes in either of the interacting protein, a correlation exists 
between the average docking score of native-like poses and the standard free energy of binding, we 
performed in silico mutations to generate the variants shown to disrupt the dimer and shift the 
equilibrium toward the monomer, namely F73E, H19R, V77E, and Y22D [15]. Interestingly, for all of 
the three dimers, the mutations resulted in a lower number of native-like poses still fulfilling the 
DEER distance constraints (Table 3). The computational analysis of the 12 mutagenized homodimers 
(ZDOCK 2.3; Table 3), shows for all the structures a shift toward the monomeric form, in line with 
the experimental results [15], though to a different extent (Table 3). Indeed, for every assembly, the 
H19R variant has a greater effect on the stability of the dimer. The predicted effects of the four point 
mutations on the ΔΔG0 values are high for all the dimers but are especially apparent for d1′, for which 
a 4.5 to 5.8 kcal/mol effect was predicted, which would strongly shift the equilibrium toward the 
monomeric form. 
Considering together the agreement with SAXS data and the overall Z-DOCK results we can 
select d1 and d2 as the best dimeric assemblies with the lower “dynamical” χ2 vs. SAXS data, the 
highest docking score, and the higher perturbing effect of the mutations on the dimeric assembly. 
The good agreement of the d1 dynamical model with SAXS data is further shown in the superposition 
with one of the low-resolution DAMMIF models (NSD 1.67; Figure 5C). 
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Figure 5. SEC-SAXS data of hGCAP1 dimer. (A) GNOM fitting (red line) of the SEC-SAXS data (blue 
points) at the higher protein concentration and corresponding P(R). (B) Dynamical EOM models of 
the 3 dimeric assemblies—d1-d3—in cartoons with transparency depending on the occupation of each 
structure on the assembly. (C) Superposition of the dynamical model d1 (blue cartoon) on one of the 
most representative low-resolution models (DAMMIF, P2 symmetry, ensemble resolution = 29 ± 2 Å, 
NSD 1.67) depicted as the cyan surface in 2 different orientations. (D) Different orientation of the 
monomers d1′—blue cartoons and d2′—green cartoons in the static dimeric assemblies (the 
superposed monomer is shown as white transparent cartoons). 
Table 2. Agreement with SAXS data and ZDOCK analysis and for the 3 selected models d1′,d2′,d3′. 
Assembly ′Static′ χ
2 
with SAXS a 
′Dynamic′ χ2 








d1′ 2.42 1.16 54.4 ± 0.8 22 1 
d2′ 1.95 1.17 44.5 ± 0.9 24 16 
d3′ 2.08 2.37 44.9 ± 0.7 16 1 
a χ2 values of selected individual structures along with the MD simulation without the C-ter. b χ2 values 
of selected mixed structures along with the MD simulation with the C-ter. c Average score of native-
like poses (i.e., within 1 Å Cα-RMSD with respect to the original complex) from multiple docking 
runs. d Rank of the native-like pose with the highest score out of 12,000 poses. 
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Table 3. Effect of the mutations on Z-dock scores and prediction of the relative free energy of binding. 






F73E 15 −13.14 5.12 
H19R 12 −14.75 5.75 
V77E 21 −11.62 4.53 
Y22D 17 −12.20 4.76 
D2′ 
F73E 12 −2.65 1.04 
H19R 8 −4.85 1.89 
V77E 9 −4.15 1.62 
Y22D 9 −4.70 1.84 
* ∆∆G0 was calculated by using an empirical correlation between ZD-s and ∆G0 as explained in [27] and in [40]. 
3.11. Insights into the Molecular Interface of the Most Likely Dimers d1 and d2 
The different orientation between the monomers in the alternative dimeric assemblies d1′ and 
d2′ is shown in Figure 5D, evidencing a rotation of about 60°. Molecular dynamics simulations 
showed that the interface between dimers d1 and d2 involved persistent electrostatic interactions 
between the negatively charged residues of the EF2 loop involved in Ca2+-coordination, namely D68, 
D72, and E75, and the positively charged residues of the entering helix of EF3 (Figure S5), namely 
R93 and K97, although with peculiarities for each dimer. Specifically, dimer d1 exhibited persistent 
interactions between R93 and D68 (70.6% of the simulation time), R93 and D72 (18.3%), and R93 and 
E75 (18.7%). Such switching electrostatic interactions hinged on R93 were completely absent in dimer 
d2, which on the other hand showed electrostatic interactions hinged on K97 (with D68 (7.1%), D72 
(72.9%), and E75 (18%)), also negligible in d1. 
When an accurate analysis of the static interface of dimers d1′ and d2′ was performed by 
Bioluminate (version 3.9.072, Schroedinger), a slightly increased buried solvent accessible surface 
area for d2′ (245.1 Å2) with respect to d1′ (219.4 Å2) with a similar shape complementarity score (2487 
vs. 2541) were measured. Interestingly, F73 was found to be involved in a π-stacking interaction in 
both interfaces, specifically with Y22 in dimer d1′ and with F65 in dimer d2′. Finally, the static analysis 
confirmed the electrostatic interactions involving D72 specifically with R93 in d1′ (salt bridge) and 
with K97 in d2′ (charge-reinforced H-bond), which could contribute to the highest docking score (ZD-
s) of the first dimeric assembly (Table 2). In conclusion, both static and dynamic analyses of the 
dimeric interfaces show a balance of stabilizing interactions, that does not allow to define which one 
among d1′ and d2′ is the most representative hGCAP1 dimer. 
4. Discussion 
SAXS data on hGCAP1 at a low concentration (10.9 µM) without Ca2+ or Mg2+ are compatible 
with a monomeric protein whose structure is in good agreement with the crystal structure of chicken 
GCAP1 as long as the C-ter end is included in a loose conformation (causing the increase of the radius 
of gyration from 19.8 to 21.0 Å). 
Purified hGCAP1 analyzed with different experimental techniques shows the equilibrium 
between monomer and dimer. Since the protein has a theoretical isoelectric point of 4.4 and is 
negatively charged at physiological pH, we expect a prevailing effect of electrostatic repulsions at 
low salt concentration shifting the equilibrium towards the monomeric state, as observed in SEC-
MALS experiments. The electrostatic repulsion is partially shielded by binding one/two Mg2+ ions or, 
to a greater extent, by three Ca2+ ions. Indeed, we observed that at low salt concentration the addition 
of a small amount (1 mM) of calcium is sufficient to push the monomeric state toward the monomer-
dimer equilibrium. In conditions closer to the physiological state, i.e., at medium salt concentration 
and in the Ca2+-bound state, hGCAP1 displays a monomer-dimer equilibrium with Kd~9 µM. When 
the 3 calcium ions are exchanged with one/two Mg2+ the higher electrostatic repulsion screen 
decreases the dimerization Kd (~60 µM). 
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Interestingly, also the chicken protein, despite being monomeric in the crystal structure, displays 
a similar dynamic monomer-dimer equilibrium (not shown), showing that this property is common 
to different GCAP1 orthologs. 
The shift toward dimeric assembly favored in the presence of Ca2+ can also explain the protein 
resistance to trypsin with respect to the unbound state observed in previous works [41,42]. 
The differences in monomer-dimer equilibrium suggest conformational changes induced by 
GCAP1 ligation state as observed with Trp fluorescence experiments, that are likely related to GCAP1 
regulatory activity on retGC1, as suggested by thorough MD simulations [19]. 
Using a combination of computational techniques, we produced 3 models of reliable dimeric 
interfaces compatible with the restrains reported by Lim et al., [15]. In every model, the dimeric 
interface is based on the N-terminal domain of GCAP1, already known to be involved in both protein 
dimerization and the interaction with retGC1 [6]. Our docking simulations confirmed the crucial role 
of the residues identified in bovine GCAP1 by Lim et al. [15] in stabilizing the dimeric assembly, as 
their in silico substitutions resulted in a dramatic increase of ΔΔG0 values, compatible with a shift of 
hGCAP1 to its monomeric form. It is interesting to highlight that the higher destabilization is 
associated with the substitution involving H19 for both d1′ and d2′ (Table 3). The H19Y mutation was 
recently identified in patients diagnosed with retinitis pigmentosa [13]. Indeed, the mutant showed 
a profound shift in Ca2+-sensitivity of RetGC regulation and, in line with our present observations, its 
oligomeric equilibrium did not shift to the dimer in the presence of Ca2+, thus suggesting a correlation 
between GCAP1 physiological role and its dimerization. 
5. Conclusions 
Monomer–dimer equilibrium in proteins is determined by a subtle balance between stabilizing 
and destabilizing forces [43]. Based on our models, only a small accessible surface area is buried on 
dimer formation (~9% of the total protein surface). Such surface is nonetheless sufficient to create 
strong electrostatic and shape complementarity between the monomers and suggests a high 
contribution of the hydrophobic effect to the process of desolvation of the protein–protein interface, 
which is reflected in the high docking scores (Table 2). The hydrophobic contacts at the GCAP1 dimer 
interface have been proven to be essential for both its dimerization and for the activation of RetGC, 
which is itself a dimer, thus suggesting that the GCAP1 dimer may bind to the cyclase target to form 
a 2:2 complex, whose allosteric regulation of catalytic activity may involve quaternary structural 
changes in a protein-protein complex [16]. An alternative explanation for the role of bGCAP1 
dimerization has been proposed by Lim et al. [15]. In the absence of bRetGC, the dimeric nature of 
bGCAP1 in the photoreceptor inner segment may prevent its diffusion into the outer segment. The 
partial overlap of the bGCAP1-bRetGC and bGCAP1-bGCAP1 interface suggests that, as soon as 
retGC becomes available, a tight intermolecular interaction would occur, which allows the mature 
RetGC/GCAP1 complex to incorporate in transport vesicles that are then transported to the outer 
segments, where the complex could then translocate into disk membranes [15]. However, the actual 
physiological role of GCAP1 dimerization in human photoreceptors is not completely clarified and 
is only partially compatible with such a hypothesis. Assuming that the intracellular concentration of 
hGCAP1 is similar to that of bGCAP1 in bovine rod outer segments [44], namely 3.3 µM, our 
experimentally determined Kd values would lead to ~33% of hGCAP1 being dimeric at high Ca2+, 
and only ~9% at low Ca2+, in the Mg2+-bound state. The apparent affinity of hGCAP1 for hRetGC (3.2 
µM, see [30] is 3-fold higher than the affinity of dimerization in the presence of Ca2+ (9 µM) and 19-
fold higher than that in Mg2+ (~60 µΜ), therefore hGCAP1 would rather bind to its target regulator 
than to itself under both conditions. Dimerization of hGCAP1 could then rather serve as a regulatory 
mechanism to prevent an excessive diffusion to the outer segment in the absence of RetGC, and not 
necessarily a condition to achieve a 2:2 complex. An updated estimate of the intracellular 
concentration of both GCAP1 and retGC in human photoreceptors is therefore necessary to clear up 
the actual molecular scenario. 
GCAP1 structural changes related to the presence of Ca2+ or Mg2+ are reflected in the observed 
changes of the dimer dissociation constant. Such conformational changes are likely related to the 
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mechanisms of GCAP1 to control the activity of the retGC1 partner, and therefore their investigation 
here described represents a step forward to dissect the structural bases of the regulatory mechanism 
of GCAP1. 
Supplementary Materials: The following are available online at www.mdpi.com/2218-273X/10/10/1408/s1, 
Figure S1: Thermal denaturation of hGCAP1 with (green line) and without Ca2+ (blue line) using circular 
dichroism spectroscopy; Figure S2: Scaled curves of GCAP1 Trp fluorescence in different conditions: it is possible 
to note the redshift of the peak corresponding to Ca2+-bound protein; Figure S3: Agreement between SAXS data 
and dimeric models d1, d2 and d3 without the last 8 residues at the C-ter (calculated using program Crysol) 
along with the 200 ns MD simulations; Figure S4: Agreement between SAXS data and dimeric models d1, d2 and 
d3 (calculated using program Crysol) along with the 200 ns MD simulation; Figure S5: Orientation of monomer 
B with respect to monomer A in dimers d1′ and d2′ and different pattern of electrostatic interactions. 
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